LRRK2 activation in idiopathic Parkinson's disease.
Saved in:
| Title: | LRRK2 activation in idiopathic Parkinson's disease. |
|---|---|
| Authors: | Di Maio R; Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, PA 15213, USA.; Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, USA.; Ri.MED Foundation, Palermo, Italy., Hoffman EK; Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, PA 15213, USA.; Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, USA., Rocha EM; Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, PA 15213, USA.; Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, USA., Keeney MT; Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, PA 15213, USA.; Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, USA., Sanders LH; Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, PA 15213, USA.; Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, USA.; Department of Neurology, Duke University, Durham, NC 27710, USA., De Miranda BR; Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, PA 15213, USA.; Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, USA., Zharikov A; Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, PA 15213, USA.; Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, USA., Van Laar A; Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, PA 15213, USA.; Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, USA., Stepan AF; Worldwide Medicinal Chemistry, Pfizer Worldwide Research and Development, Cambridge, MA 02139, USA., Lanz TA; Worldwide Medicinal Chemistry, Pfizer Worldwide Research and Development, Cambridge, MA 02139, USA., Kofler JK; Department of Pathology, University of Pittsburgh, Pittsburgh, PA 15213, USA., Burton EA; Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, PA 15213, USA.; Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, USA.; Geriatric Research, Education and Clinical Center, VA Pittsburgh Healthcare System, Pittsburgh, PA 15240, USA., Alessi DR; MRC Protein Phosphorylation and Ubiquitylation Units, University of Dundee, Dundee, Scotland., Hastings TG; Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, PA 15213, USA.; Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, USA., Greenamyre JT; Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh, Pittsburgh, PA 15213, USA. jgreena@pitt.edu.; Department of Neurology, University of Pittsburgh, Pittsburgh, PA 15213, USA.; Geriatric Research, Education and Clinical Center, VA Pittsburgh Healthcare System, Pittsburgh, PA 15240, USA. |
| Source: | Science translational medicine [Sci Transl Med] 2018 Jul 25; Vol. 10 (451). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
